BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29758936)

  • 1. Evaluation of integrated color-coded perfusion analysis for contrast-enhanced ultrasound (CEUS) after percutaneous interventions for malignant liver lesions: First results.
    Wiesinger I; Beyer LP; Zausig N; Verloh N; Wiggermann P; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2018; 69(1-2):59-67. PubMed ID: 29758936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
    Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
    J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies.
    Rennert J; Wiesinger I; Beyer LP; Schicho A; Stroszczynski C; Wiggermann P; Jung EM
    Clin Hemorheol Microcirc; 2019; 73(1):73-83. PubMed ID: 31561352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative perfusion analysis of hepatocellular carcinoma using dynamic contrast enhanced ultrasound (CEUS) to determine tumor microvascularization.
    Schaible J; Stroszczynski C; Beyer LP; Jung EM
    Clin Hemorheol Microcirc; 2019; 73(1):95-104. PubMed ID: 31561349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous Treatment of Malignant Liver Lesions: Evaluation of Success Using Contrast- Enhanced Ultrasound (CEUS) and Perfusion Software.
    Wiesinger I; Wiggermann P; Zausig N; Beyer LP; Salzberger B; Stroszczynski C; Jung EM
    Ultraschall Med; 2018 Aug; 39(4):440-447. PubMed ID: 28946152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
    Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
    Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
    Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
    Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone.
    Lekht I; Gulati M; Nayyar M; Katz MD; Ter-Oganesyan R; Marx M; Cen SY; Grant E
    Abdom Radiol (NY); 2016 Aug; 41(8):1511-21. PubMed ID: 26969495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: First results.
    Jung EM; Ross CJ; Rennert J; Scherer MN; Farkas S; von Breitenbuch P; Schnitzbauer AA; Piso P; Lamby P; Menzel C; Schreyer AG; Feuerbach S; Schlitt HJ; Loss M
    Clin Hemorheol Microcirc; 2010; 46(2-3):89-99. PubMed ID: 21135485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Color coded perfusion imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following trans-arterial chemoembolization (TACE) of hepatocellular carcinoma.
    Rennert J; Wiesinger I; Schicho A; Beyer LP; Wiggermann P; Stroszczynski C; Jung EM
    PLoS One; 2019; 14(6):e0217599. PubMed ID: 31181127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results.
    Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of malignant liver tumors by software-based perfusion quantification with dynamic contrast-enhanced ultrasound (DCEUS).
    Wildner D; Schellhaas B; Strack D; Goertz RS; Pfeifer L; Fiessler C; Neurath MF; Strobel D
    Clin Hemorheol Microcirc; 2019; 71(1):39-51. PubMed ID: 29865043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.
    Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM
    Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficiency of contrast enhanced ultrasound for immediate assessment of ablation status after intraoperative radiofrequency ablation of hepatic malignancies.
    da Silva NPB; Beyer LP; Hottenrott MC; Hackl C; Schlitt HJ; Stroszczynski C; Wiggermann P; Jung EM
    Clin Hemorheol Microcirc; 2017; 66(4):357-368. PubMed ID: 28598835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Liver Tumors Using Preoperative and Intraoperative Contrast-Enhanced Ultrasound (CEUS/IOCEUS) by Radiologists in Comparison to Magnetic Resonance Imaging and Histopathology.
    Huf S; Platz Batista da Silva N; Wiesinger I; Hornung M; Scherer MN; Lang S; Stroszczynski C; Fischer T; Jung EM
    Rofo; 2017 May; 189(5):431-440. PubMed ID: 28449169
    [No Abstract]   [Full Text] [Related]  

  • 18. Contrast enhanced ultrasound (CEUS) with parametric imaging after irreversible electroporation (IRE) of the prostate to assess the success of prostate cancer treatment.
    Jung EM; Engel M; Wiggermann P; Schicho A; Lerchbaumer M; Stroszczynski C; Fischer T; Wiesinger I
    Clin Hemorheol Microcirc; 2021; 77(3):303-310. PubMed ID: 33337354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors.
    Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D
    Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of arterial dynamic micro-vascularization with contrast-enhanced ultrasound (CEUS) in thyroid lesions using external perfusion software: First results.
    Wiesinger I; Kroiss E; Zausig N; Hornung M; Zeman F; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2016; 64(4):747-755. PubMed ID: 27792004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.